"Long QT Syndrome" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A condition that is characterized by episodes of fainting (SYNCOPE) and varying degree of ventricular arrhythmia as indicated by the prolonged QT interval. The inherited forms are caused by mutation of genes encoding cardiac ion channel proteins. The two major forms are ROMANO-WARD SYNDROME and JERVELL-LANGE NIELSEN SYNDROME.
Descriptor ID |
D008133
|
MeSH Number(s) |
C14.280.067.565 C14.280.123.625 C16.131.240.400.715 C23.550.073.547
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Long QT Syndrome".
Below are MeSH descriptors whose meaning is more specific than "Long QT Syndrome".
This graph shows the total number of publications written about "Long QT Syndrome" by people in this website by year, and whether "Long QT Syndrome" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2007 | 1 | 0 | 1 |
2009 | 2 | 0 | 2 |
2013 | 2 | 0 | 2 |
2014 | 1 | 0 | 1 |
2015 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 18 | 1 | 19 |
2018 | 17 | 2 | 19 |
2019 | 9 | 2 | 11 |
2020 | 23 | 7 | 30 |
2021 | 8 | 7 | 15 |
2022 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Long QT Syndrome" by people in Profiles.
-
QTc prolongation and mortality in SARS-2-CoV-infected patients treated with azithromycin and hydroxychloroquine. J Cardiovasc Med (Hagerstown). 2022 01 01; 23(1):e21-e23.
-
QTc Interval Prolongation and Life-Threatening Arrhythmias During Hospitalization in Patients With Coronavirus Disease 2019 (COVID-19): Results From a Multicenter Prospective Registry. Clin Infect Dis. 2021 12 06; 73(11):e4031-e4038.
-
Adverse drug event risk assessment by the virtual addition of COVID-19 repurposed drugs to Medicare and commercially insured patients' drug regimens: A drug safety simulation study. Clin Transl Sci. 2021 09; 14(5):1799-1809.
-
Effect of hydroxychloroquine on the cardiac ventricular repolarization: A randomized clinical trial. Br J Clin Pharmacol. 2022 03; 88(3):1054-1062.
-
Current evidence for the risk of PR prolongation, QRS widening, QT prolongation, from lopinavir, ritonavir, atazanavir, and saquinavir: A systematic review. Medicine (Baltimore). 2021 Aug 06; 100(31):e26787.
-
The 12-Lead ECG in COVID-19: QT Prolongation Predicts Outcome. JACC Clin Electrophysiol. 2021 08; 7(8):1072-1073.
-
Modelling sudden cardiac death risks factors in patients with coronavirus disease of 2019: the hydroxychloroquine and azithromycin case. Europace. 2021 07 18; 23(7):1124-1133.
-
Frequent Premature Ventricular Contraction and Non-Sustained Ventricular Tachycardia After the SARS-CoV-2 Vaccination in Patient With Implantable Cardioverter Defibrillator Due to Acquired Long-QT Syndrome. Circ J. 2021 10 25; 85(11):2117.
-
Corrected QT interval in hospitalized patients with coronavirus disease 2019: Focus on drugs therapy. Medicine (Baltimore). 2021 Jul 16; 100(28):e26538.
-
QT Interval Monitoring with Handheld Heart Rhythm ECG Device in COVID-19 Patients. Glob Heart. 2021 06 08; 16(1):42.